News Archive - 2018

News Archive - 2018

UK Bioindustry Association (BIA) launches new Genomics Advisory Committee at annual Committee Summit

ibrahim.jpg

UK Bioindustry Association (BIA) launches new Genomics Advisory Committee at annual Committee Summit

The UK Bioindustry Association (BIA) launched its newest Advisory Committee, focused on the issue of genomics, chaired by Adrian Ibrahim from the Wellcome Sanger Institute's Innovations team.

The Committee will act as a leadership platform for sharing and discussing issues of common concern between genomic businesses and will provide expert advice on important issues such as the use of data and embedding genomic medicine in the NHS.

Typhoid outbreak: genetic cause of extensive drug resistance found

Clean water provision in Sindh, Pakistan. Currently there is a spreading outbreak of extensively drug resistant (XDR) typhoid in the region

Typhoid outbreak: genetic cause of extensive drug resistance found

The results suggest that treatment options for typhoid treatment are running out and preventative strategies are needed

The genetic cause behind a strain of typhoid’s resistance to five classes of antibiotics has been uncovered by scientists at the Wellcome Sanger Institute and their collaborators at Public Health England and Aga Khan University, Pakistan. This study shows the typhoid strain causing the outbreak acquired an additional piece of DNA to become resistant to multiple antibiotics, including a third-generation antibiotic.

Major funding for Cambridge to transform health through data science

HDRUK

Major funding for Cambridge to transform health through data science

Cambridge is amongst six sites across the UK to be awarded a total of £30M funding by Health Data Research UK, to address challenging healthcare issues through use of data science.

Each of the six sites already work in close partnership with NHS bodies and the public to translate research findings into benefits for patients and populations. From April this year, the sites will work collaboratively as foundation partners in Health Data Research UK to make game-changing improvements in people’s health by harnessing data science at scale across the UK.

Is food love-hate coded in your DNA?

foodlovehate.jpg

Is food love-hate coded in your DNA?

This Valentine’s special is the first of an exciting new programme of monthly Café Sci events in Cambridge

Can your DNA say if you love or hate Marmite, or prefer a Malbec over Merlot? Genetic testing is hitting the mainstream, but what can your DNA actually reveal about you? Join us on Valentine’s night for the first event of a lively new series of Café Sci to find out more about the real science truths, and discuss how you think genetic data should be used.

Multidrug resistant malaria spread under the radar for years in Cambodia

photo_credit_Chanaki_Amaratunga.jpg

Multidrug resistant malaria spread under the radar for years in Cambodia

Study suggests that ongoing genomic surveillance is vital to inform malaria control strategies

The most comprehensive genetic study of malaria parasites in Southeast Asia has shown that resistance to antimalarial drugs was under-reported for years in Cambodia. Researchers from the Wellcome Sanger Institute and their collaborators have shown that the parasites developed multidrug resistance to first-line treatments extremely rapidly.

Sarah Teichmann awarded the Genetics Society’s 2018 Mary Lyon Medal

sarah.jpg

Sarah Teichmann awarded the Genetics Society’s 2018 Mary Lyon Medal

Award recognises Dr Teichmann’s “outstanding research” in understanding how the immune system works by using genomics and bioinformatics approaches

Wellcome Sanger Institute Group Leader Dr Sarah Teichmann has received the prestigious Mary Lyon Medal 2018. This annual recognition, named after the distinguished geneticist Mary Lyon FRS, rewards outstanding research in genetics by scientists who are in the middle of their research career. As part of the award, Sarah has been invited to present a lecture at one of the Genetics Society’s scientific meetings.

Hidden genetic effects behind immune diseases may be missed, study suggests

macrophages_hompage2.jpg

Hidden genetic effects behind immune diseases may be missed, study suggests

For the first time immune cells created from human induced pluripotent stem cells (HiPSCs) have been used to model immune response variation between people

The role of genetics in the risk of having an immune disease could be missed in research, scientists suggest. Using a combination of stem cells and novel analytical tools, scientists at the Wellcome Sanger Institute and their collaborators discovered that clues to the contribution of genetic variation to disease risk lie not only in the genes, but also in the molecular switches that control those genes.

BioBright, Sanger Institute aim to cut drug-development time

Gosia Trynka (left) and Charles Fracchia, BioBright CEO, are employing BioBright tools in Trynka’s lab at the Wellcome Sanger Institute

BioBright, Sanger Institute aim to cut drug-development time

Collaboration promises better, more reproducible biomedical data

BioBright, a firm dedicated to creating the smart laboratory of the future, has announced a collaboration with the Wellcome Sanger Institute that could lead to the faster development of drugs for diseases of the immune system like rheumatoid arthritis.